Vanguard Group Portfolio holdings
The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$1.53B |
| 2 |
American Tower
AMT
|
+$1.49B |
| 3 |
McDonald's
MCD
|
+$1.13B |
| 4 |
Crown Castle
CCI
|
+$1.07B |
| 5 |
Alibaba
BABA
|
+$970M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SNI
Scripps Networks Interactive, Inc Common Class A
SNI
|
+$762M |
| 2 |
Amgen
AMGN
|
+$595M |
| 3 |
BIVV
Bioverativ Inc. Common Stock
BIVV
|
+$497M |
| 4 |
CPN
Calpine Corporation
CPN
|
+$468M |
| 5 |
POT
Potash Corp Of Saskatchewan
POT
|
+$427M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.46% |
| 2 | Financials | 16.15% |
| 3 | Healthcare | 12.31% |
| 4 | Industrials | 10.73% |
| 5 | Consumer Discretionary | 9.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KALV
3626
DELISTED
KalVista Pharmaceuticals
KALV
| $1.11M | ﹤0.01% |
117,095
-1,243
| -1% | -$13K |
|
|
DEST
3627
DELISTED
Destination Maternity Corporation
DEST
| $1.1M | ﹤0.01% |
424,982
+98,382
| +30% | +$238K |
|
3628
Lisata Therapeutics
LSTA
$9.74M
| $1.09M | ﹤0.01% |
12,497
+5,693
| +84% | +$394K |
|
3629
Lipocine
LPCN
$17.6M
| $1.09M | ﹤0.01% |
42,038
+2,777
| +7% | +$77.3K |
|
|
XPLR
3630
DELISTED
Xplore Technologies Corp.
XPLR
| $1.09M | ﹤0.01% |
336,824
+39,677
| +13% | +$122K |
|
|
ALJJ
3631
DELISTED
ALJ Regional Holdings Inc
ALJJ
| $1.07M | ﹤0.01% |
511,348
+35,888
| +8% | +$99.2K |
|
|
ESBK
3632
DELISTED
Elmira Savings Bank Elmira NY
ESBK
| $1.07M | ﹤0.01% |
55,460
+1,836
| +3% | +$35.9K |
|
|
XIN
3633
DELISTED
Xinyuan Real Estate
XIN
| $1.07M | ﹤0.01% |
20,245
+2,028
| +11% | +$136K |
|
3634
Tempest Therapeutics
TPST
$14.4M
| $1.07M | ﹤0.01% |
450
+5
| +1% | +$15K |
|
|
ATXS
3635
DELISTED
Astria Therapeutics
ATXS
| $1.06M | ﹤0.01% |
9,745
+465
| +5% | +$46.5K |
|
|
BNBX
3636
DELISTED
BNB PLUS CORP
BNBX
| $1.05M | ﹤0.01% |
1
| – | – |
|
|
EVOK
3637
DELISTED
Evoke Pharma
EVOK
| $1.05M | ﹤0.01% |
3,513
-12
| -0.3% | -$3.95K |
|
|
SCX
3638
DELISTED
The L.S. Starrett Company
SCX
| $1.04M | ﹤0.01% |
154,109
-1,990
| -1% | -$16.2K |
|
|
OXFD
3639
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $1.03M | ﹤0.01% |
83,007
+3,415
| +4% | +$41.6K |
|
3640
NanoViricides
NNVC
$35.7M
| $1.03M | ﹤0.01% |
62,675
+611
| +1% | +$11.3K |
|
3641
Virco
VIRC
$95.2M
| $1.02M | ﹤0.01% |
248,840
+13,699
| +6% | +$61.8K |
|
|
AAMC
3642
DELISTED
Altisource Asset Management Corp
AAMC
| $1.02M | ﹤0.01% |
27,793
+850
| +3% | +$33.5K |
|
3643
Friedman Industries
FRD
$272M
| $1.02M | ﹤0.01% |
173,279
+4,099
| +2% | +$23.9K |
|
3644
PDS Biotechnology
PDSB
$41.8M
| $1.02M | ﹤0.01% |
43,027
+66
| +0.2% | +$17.8K |
|
|
VERO
3645
DELISTED
Venus Concept
VERO
| $1.01M | ﹤0.01% |
66
+22
| +50% | +$293K |
|
3646
Vanguard Materials ETF
VAW
$3.08B
| $1M | ﹤0.01% |
7,792
+120
| +2% | +$16.4K |
|
|
CBK
3647
DELISTED
Christopher & Banks Corporation
CBK
| $1M | ﹤0.01% |
938,657
+24,911
| +3% | +$29K |
|
3648
Red Violet
RDVT
$950M
| $1M | ﹤0.01% |
+164,256
| New | +$987K |
|
3649
Espey Mfg & Electronics Corp
ESP
$186M
| $985K | ﹤0.01% |
37,579
-400
| -1% | -$10.1K |
|
3650
Moleculin Biotech
MBRX
$2.72M
| $984K | ﹤0.01% |
243
+39
| +19% | +$169K |
|
Similar funds
Vanguard Group's Q1 2018 Portfolio in Review
As of Q1 2018, Vanguard Group held 4,163 positions worth $2.29T, down 0.01% from $2.29T the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Trading was light in Q1 2018: portfolio turnover was 3.9%. Vanguard Group opened 99 new positions and exited 63, leaving the 4,163-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
- Vanguard Group's largest Q1 2018 buy was Nutrien: 16,386,239 shares worth $774M.
- Vanguard Group added most to Walmart Inc in Q1 2018, an estimated $1.53B increase.
- Vanguard Group's biggest Q1 2018 reduction was Amgen, cutting an estimated $595M.
- Vanguard Group fully exited Scripps Networks Interactive, Inc Common Class A in Q1 2018, selling an estimated $762M.
- Vanguard Group's ten largest holdings make up 14% of its $2.29T portfolio in Q1 2018.
- Vanguard Group opened 99 new positions and closed 63 in Q1 2018.
- Vanguard Group's portfolio value fell 0.01% quarter-over-quarter to $2.29T.
Based on Vanguard Group's 13F filing for Q1 2018, filed 15 May 2018.